A Pilot Phase II Trial of Continuous-Infusion Interleukin-2 Followed by Lymphokine-Activated Killer Cell Therapy and Bolus-Infusion Interleukin-2 in Renal Cancer.

Autor: Gambacorti-Passerini, Carlo, Hank, Jacquelyn A., Albertini, Mark R., Borchert, Agnes A., Moore, Karen H., Schiller, Joan H., Bechhofer, Robin, Borden, Ernest C., Storer, Barry, Sondel, Paul M.
Zdroj: Journal of Immunotherapy; Jan1993, Vol. 13 Issue 1, p43-48, 6p
Databáze: Complementary Index